Anheuser-Busch Inbev shares rose more than 5% on Wednesday, in response to a strong first-quarter performance and anticipated relief from the impact of an ongoing U.S. Bud Light boycott.
The world's largest brewer reported a 2.6% rise in revenues, in line with expectations, and better-than-forecast EBITDA and volumes, including in North America, its largest region by revenues, analysts said.
A-B Inbev's sales in the U.S. were down 9.1%, however, with sales to retailers in America dropping by 13.7%, primarily due to the Bud Light boycott.
AB Inbev sales in the United States have been hit hard by a consumer boycott of Bud Light that knocked it from the top spot as the best-selling U.S. beer.
The company, which makes Stella Artois and Corona beer, said it had record volumes in some of its markets, including Brazil and South Africa. EBITDA, meanwhile, grew 5.4%, well ahead of the 1.9% expected by analysts.
Its shares hit their highest level since February, putting them among the biggest gainers on the pan-European STOXX 600 .
"We are encouraged by our results to start the year," Chief Executive Michel Doukeris said.
"ABI has got its (likely) hardest quarter of 2024 out of the way with little to no bruises," Barclays analyst Laurence Whyatt said. "Bud Light continues to weigh on results, but this is the last quarter to face a significant impact."
The boycott is related to a conservative backlash against a social media promotion with transgender influencer Dylan Mulvaney.
It began about a year ago, which means that the three months to end-March should be the final quarter of real pain for AB InBev in terms of tough comparatives.
Sales figures from a year ago will include the boycott from here on out, making the comparatives less painful.
All brewers are set for margin expansion as price rises for key supplies from barley to aluminum slow.
Rivals Heineken and Carlsberg also produced solid first-quarter results.
AB InBev reported a 5.4% increase in normalized EBITDA to almost $5 billion. The company said it expects full-year EBITDA to grow in line with its medium-term outlook of between 4% and 8%.
© 2024 Thomson/Reuters. All rights reserved.